Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 6/20 | 0.55 |
| ▸ | PPARD | Q03181 | 5/20 | 0.55 |
| ▸ | PPARA | Q07869 | 5/20 | 0.55 |
| ▸ | TERT | O14746 | 3/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | BLM | P54132 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | FABP4 | P15090 | 3/20 | 0.55 |
| ▸ | TOP1 | P11387 | 3/20 | 0.55 |
| ▸ | USP2 | O75604 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | RECQL | P46063 | 2/20 | 0.55 |
| ▸ | F7 | P08709 | 2/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.55 |
| ▸ | F3 | P13726 | 2/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.55 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7647197 | 1.00 | PPARG (0.55) | PPARGPPARDPPARATERTPTPN1 | |
| SCHEMBL5598319 | 0.98 | TERT (0.58) | PPARGPPARDPPARATERTPTPN1 | |
| SCHEMBL7575667 | 0.98 | TERT (0.58) | PPARGPPARDPPARATERTPTPN1 | |
| SCHEMBL20529764 | 0.98 | TERT (0.58) | PPARGPPARDPPARATERTPTPN1 | |
| SCHEMBL7575671 | 0.98 | TERT (0.58) | PPARGPPARDPPARATERTPTPN1 | |
| SCHEMBL18640772 | 0.98 | TERT (0.58) | PPARGPPARDPPARATERTPTPN1 | |
| SCHEMBL20529741 | 0.96 | F7 (0.55) | PPARGPPARDPPARATERTPTPN1 | |
| SCHEMBL20529739 | 0.96 | F7 (0.55) | PPARGPPARDPPARATERTPTPN1 | |
| SCHEMBL12501477 | 0.88 | ALDH1A1 (0.41) | PPARGPPARDPPARATERTPTPN1 | |
| SCHEMBL12501476 | 0.88 | ALDH1A1 (0.41) | PPARGPPARDPPARATERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210324029-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | Bioniz Therapeutics, Inc. | 2021-10-21 | — | — | US | claimed |
| EP-3606940-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | Bioniz, LLC (US) | 2020-02-12 | — | — | EP | claimed |
| WO-2018187499-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | BIONIZ, LLC (US) | 2018-10-11 | — | — | WO | claimed |
| US-12600757-B2 | Peptides inhibiting gamma-c-cytokine activity and methods of use | Bioniz Therapeutics, Inc. (US) | 2026-04-14 | — | — | US | disclosed |
| US-20210324029-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | Bioniz Therapeutics, Inc. | 2021-10-21 | — | — | US | disclosed |
| EP-3606940-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | Bioniz, LLC (US) | 2020-02-12 | — | — | EP | disclosed |
| WO-2018187499-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | BIONIZ, LLC (US) | 2018-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600757-B2 | Peptides inhibiting gamma-c-cytokine activity and methods of use | IL15, IL2, IL15RA | PPARG 998/4885PPARD 2442/4885PPARA 2161/4885 |
| US-20210324029-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | IL2, IL2RA, GMFG | PPARG 1025/4885PPARD 3011/4885PPARA 2300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.